Garton & Associates Financial Advisors’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
Garton & Associates Financial Advisors's XYL Position: Q1 2026 in Review
Garton & Associates Financial Advisors sold out of Xylem (XYL) in Q1 2026, closing a stake of 102 shares — an estimated $13.9K sold.
Garton & Associates Financial Advisors first reported a position in XYL in Q4 2025 and held it in 1 quarter. The position peaked at $13.9K in Q4 2025. 1,111 funds tracked by Wall St. Rank hold XYL as of Q1 2026.
- Garton & Associates Financial Advisors reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
- Garton & Associates Financial Advisors sold 102 Xylem shares in Q1 2026, an estimated $13.9K.
- Garton & Associates Financial Advisors first reported a position in Xylem in Q4 2025 and held it in 1 quarter.
- Garton & Associates Financial Advisors's Xylem position peaked at $13.9K in Q4 2025.
- 1,111 funds tracked by Wall St. Rank held Xylem as of Q1 2026.
Based on Garton & Associates Financial Advisors's 13F filing for Q1 2026, filed 11 May 2026.